Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 3 , Pages 393-401 , September 2007

Age-specific changes in sex steroid biosynthesis and sex development

  • Nils Krone, MD (Wellcome Trust Clinician Scientist Fellow)
  • Wiebke Arlt, MD, DSc, FRCP (Professor of Medicine, MRC Senior Clinical Fellow)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 121 415 8716; Fax: +44 121 415 8712.

References 

  1. Hanley NA, Hagan DM, Clement-Jones M, et al. SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development. Mechanisms of Development. 2000;91:403–407
  2. Parker KL, Schimmer BP. Genes essential for early events in gonadal development. Annals of Medicine. 2002;34:171–178
  3. Wilhelm D, Palmer S, Koopman P. Sex determination and gonadal development in mammals. Physiological Reviews. 2007;87:1–28
  4. Turnpenny L, Spalluto CM, Perrett RM, et al. Evaluating human embryonic germ cells: concord and conflict as pluripotent stem cells. Stem Cells. 2006;24:212–220
  5. Visser JA. AMH signaling: from receptor to target gene. Molecular and Cellular Endocrinology. 2003;211:65–73
  6. MIM *600957. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=600957.
  7. MIM *600956. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=600956.
  8. MIM #261550. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=261550.
  9. Josso N, Belville C, di Clemente N, et al. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Human Reproduction Update. 2005;11:351–356
  10. Sobel V, Zhu YS, Imperato-McGinley J. Fetal hormones and sexual differentiation. Obstetrics and Gynecology Clinics of North America. 2004;31:837–841
  11. MIM *607306. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=607306.
  12. Imperato-McGinley J, Guerrero L, Gautier T, et al. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186:1213–1215
  13. Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Molecular and Cellular Endocrinology. 2002;198:51–59
  14. Wilson JD. Dihydrotestosterone formation in cultured human fibroblasts. Comparison of cells from normal subjects and patients with familial incomplete male pseudohermaphroditism, Type 2. The Journal of Biological Chemistry. 1975;250:3498–3504
  15. MIM +152790. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=152790.
  16. Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocrine Reviews. 2000;21:551–583
  17. Parker KL, Rice DA, Lala DS, et al. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Progress in Hormone Research. 2002;57:19–36
  18. MIM +184757. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=184757.
  19. Achermann JC, Ito M, Ito M, et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nature Genetics. 1999;22:125–126
  20. Lin L, Philibert P, Ferraz-de-Souza B, et al. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. The Journal of Clinical Endocrinology and Metabolism. 2007;92:991–999
  21. Siiteri PK, Wilson JD. Testosterone formation and metabolism during male sexual differentiation in the human embryo. The Journal of Clinical Endocrinology and Metabolism. 1974;38:113–125
  22. Goto M, Piper HK, Marcos J, et al. In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. The Journal of Clinical Investigation. 2006;116:953–960
  23. Grumbach MM, Auchus RJ. Estrogen: consequences and implications of human mutations in synthesis and action. The Journal of Clinical Endocrinology and Metabolism. 1999;84:4677–4694
  24. Shapiro E, Huang HY, Wu XR. Uroplakin and androgen receptor expression in the human fetal genital tract: insights into the development of the vagina. The Journal of Urology. 2000;164:1048–1051
  25. Hughes IA, Houk C, Ahmed SF, et al. Consensus statement on management of intersex disorders. Archives of Disease in Childhood. 2006;91:554–563
  26. Krone N, Dhir V, Ivison HE, et al. Congenital adrenal hyperplasia and P450 oxidoreductase deficiency. Clinical Endocrinology. 2007;66:162–172
  27. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365:2125–2136
  28. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews. 2000;21:245–291
  29. MIM +201910. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=201910.
  30. David M, Forest MG. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. The Journal of Pediatrics. 1984;105:799–803
  31. Nimkarn S, New MI. Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Nature Clinical Practice. Endocrinology & Metabolism. 2007;3:405–413
  32. MIM #202110. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=202110.
  33. Kagimoto M, Winter JS, Kagimoto K, et al. Structural characterization of normal and mutant human steroid 17alpha-hydroxylase genes: molecular basis of one example of combined 17alpha-hydroxylase/17,20 lyase deficiency. Molecular Endocrinology. 1988;2:564–570
  34. Auchus RJ. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinology and Metabolism Clinics of North America. 2001;30:101–119
  35. Peterson RE, Imperato-McGinley J, Gautier T, et al. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. The New England Journal of Medicine. 1985;313:1182–1191
  36. Adachi M, Tachibana K, Asakura Y, et al. A male patient presenting with major clinical symptoms of glucocorticoid deficiency and skeletal dysplasia, showing a steroid pattern compatible with 17alpha-hydroxylase/17,20-lyase deficiency, but without obvious CYP17 gene mutations. Endocrine Journal. 1999;46:285–292
  37. Kelley RI, Kratz LE, Glaser RL, et al. Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. American Journal of Medical Genetics. 2002;110:95–102
  38. Arlt W, Walker EA, Draper N, et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet. 2004;363:2128–2135
  39. Fluck CE, Tajima T, Pandey AV, et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nature Genetics. 2004;36:228–230
  40. MIM #201750. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=201750.
  41. Dhir V, Ivison HE, Krone N, et al. Differential Inhibition of CYP17A1 and CYP21A2 Activities by the P450 Oxidoreductase Mutant A287P. Molecular Endocrinology. 2007 May 15;[epub ahead of print]
  42. MIM #207410. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=207410.
  43. Antley R, Bixler D. Trapezoidocephaly, midfacial hypoplasia and cartilage abnormalities with multiple synostoses and skeletal fractures. Birth Defects Original Article Series. 1975;11:397–401
  44. Wilson JD, Auchus RJ, Leihy MW, et al. 5alpha-androstane-3alpha,17beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha,17alpha-diol-20-one as a key intermediate. Endocrinology. 2003;144:575–580
  45. Mahendroo M, Wilson JD, Richardson JA, et al. Steroid 5alpha-reductase 1 promotes 5alpha-androstane-3alpha,17beta-diol synthesis in immature mouse testes by two pathways. Molecular and Cellular Endocrinology. 2004;222:113–120
  46. Gupta MK, Guryev OL, Auchus RJ. 5alpha-reduced C21 steroids are substrates for human cytochrome P450c17. Archives of Biochemistry and Biophysics. 2003;418:151–160

PII: S1521-690X(07)00053-X

doi: 10.1016/j.beem.2007.06.001

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 3 , Pages 393-401 , September 2007